RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 142 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $325,000 | -92.6% | 287,685 | -80.5% | 0.00% | -100.0% |
| Q1 2022 | $4,411,000 | -4.0% | 1,475,083 | -14.9% | 0.00% | 0.0% |
| Q4 2021 | $4,593,000 | -23.9% | 1,733,359 | +4.3% | 0.00% | -50.0% |
| Q3 2021 | $6,033,000 | +91.8% | 1,661,958 | +129.3% | 0.00% | +100.0% |
| Q2 2021 | $3,146,000 | -51.3% | 724,952 | -61.6% | 0.00% | -50.0% |
| Q1 2021 | $6,459,000 | -9.8% | 1,888,645 | -7.7% | 0.00% | -33.3% |
| Q4 2020 | $7,162,000 | +42.5% | 2,046,135 | -2.3% | 0.00% | +50.0% |
| Q3 2020 | $5,025,000 | +32.1% | 2,094,228 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $3,805,000 | +7.6% | 2,079,060 | -8.3% | 0.00% | 0.0% |
| Q1 2020 | $3,536,000 | -32.2% | 2,266,710 | -6.9% | 0.00% | 0.0% |
| Q4 2019 | $5,212,000 | +3.4% | 2,435,473 | -9.6% | 0.00% | 0.0% |
| Q3 2019 | $5,040,000 | -27.8% | 2,695,069 | +0.8% | 0.00% | -33.3% |
| Q2 2019 | $6,981,000 | +24.6% | 2,674,786 | +22.7% | 0.00% | +50.0% |
| Q1 2019 | $5,602,000 | +49.4% | 2,179,943 | +33.7% | 0.00% | 0.0% |
| Q4 2018 | $3,749,000 | +152.1% | 1,630,034 | +251.8% | 0.00% | +100.0% |
| Q3 2018 | $1,487,000 | +118.7% | 463,340 | +141.3% | 0.00% | – |
| Q1 2018 | $680,000 | -8.7% | 192,035 | 0.0% | 0.00% | – |
| Q4 2017 | $745,000 | +38.5% | 192,035 | -9.4% | 0.00% | – |
| Q3 2017 | $538,000 | -34.5% | 212,040 | -29.6% | 0.00% | – |
| Q2 2017 | $822,000 | -75.7% | 300,986 | -70.6% | 0.00% | -100.0% |
| Q1 2017 | $3,386,000 | +19.7% | 1,023,098 | -13.9% | 0.00% | +100.0% |
| Q4 2016 | $2,829,000 | -46.2% | 1,188,442 | -17.0% | 0.00% | -66.7% |
| Q3 2016 | $5,257,000 | +62.1% | 1,432,319 | -1.5% | 0.00% | +50.0% |
| Q2 2016 | $3,243,000 | +2.1% | 1,454,251 | -4.8% | 0.00% | 0.0% |
| Q1 2016 | $3,177,000 | -35.3% | 1,527,273 | -5.8% | 0.00% | -33.3% |
| Q4 2015 | $4,911,000 | +9.0% | 1,620,821 | -11.2% | 0.00% | 0.0% |
| Q3 2015 | $4,507,000 | -13.6% | 1,824,856 | +12.3% | 0.00% | 0.0% |
| Q2 2015 | $5,215,000 | -9.8% | 1,624,817 | +0.3% | 0.00% | -25.0% |
| Q1 2015 | $5,782,000 | +75.4% | 1,619,764 | +11.6% | 0.00% | +100.0% |
| Q4 2014 | $3,296,000 | +10.9% | 1,452,050 | -5.3% | 0.00% | 0.0% |
| Q3 2014 | $2,973,000 | -43.6% | 1,532,529 | +5.6% | 0.00% | -50.0% |
| Q2 2014 | $5,267,000 | +35.9% | 1,451,074 | +45.2% | 0.00% | +33.3% |
| Q1 2014 | $3,876,000 | +14.7% | 999,075 | -15.8% | 0.00% | 0.0% |
| Q4 2013 | $3,380,000 | -7.6% | 1,186,129 | +16.1% | 0.00% | 0.0% |
| Q3 2013 | $3,659,000 | +27.8% | 1,021,943 | +19.2% | 0.00% | 0.0% |
| Q2 2013 | $2,863,000 | – | 857,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |